calendar
2,361 catalysts · 5,159 phase readout · 2,355 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion
2,361 catalysts · 5,159 phase readout · 2,355 8k filing · 316 pdufa · 275 earnings · 108 phase 2 completion · 50 phase 1 completion
Therapy area: Ophthalmology. Indication: Wet (Neovascular / Exudative) Macular Degeneration
Therapy area: Ophthalmology. Indication: Choroidal Neovascularization
Therapy area: Genetic Disorders. Indication: Duchenne Muscular Dystrophy
Therapy area: Ophthalmology. Indication: Retinal Vein Occlusion
Therapy area: Ophthalmology. Indication: Diabetic Retinopathy
Therapy area: Ophthalmology. Indication: Diabetic Macular Edema
Items: 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 5.02
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 5.07, 9.01
Items: 5.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 7.01, 9.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 7.01, 9.01
Items: 1.01, 7.01, 9.01
Items: 2.02, 9.01
Items: 1.02
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01